|
gptkbp:instanceOf
|
gptkb:public_company
|
|
gptkbp:acquiredBy
|
gptkb:Omega_Pharma
gptkb:PBM_Holdings
HRA Pharma
|
|
gptkbp:CEO
|
gptkb:Patrick_Lockwood-Taylor
|
|
gptkbp:division
|
gptkb:Consumer_Self-Care_Americas
gptkb:Consumer_Self-Care_International
|
|
gptkbp:founded
|
1887
|
|
gptkbp:founder
|
gptkb:Luther_Perrigo
|
|
gptkbp:headquarters
|
gptkb:Allegan,_Michigan,_United_States
|
|
gptkbp:headquarters_location
|
gptkb:Dublin,_Ireland
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Perrigo Company plc
|
|
gptkbp:industry
|
pharmaceuticals
consumer healthcare
|
|
gptkbp:ISIN
|
IE00BGH1M568
|
|
gptkbp:listedOn
|
gptkb:New_York_Stock_Exchange
|
|
gptkbp:netIncome
|
$-0.29 billion (2022)
|
|
gptkbp:numberOfEmployees
|
~10,000
|
|
gptkbp:previously_headquartered_in
|
gptkb:Allegan,_Michigan,_United_States
|
|
gptkbp:products
|
infant formula
nutritional products
over-the-counter pharmaceuticals
generic prescription drugs
|
|
gptkbp:relocated_headquarters_to
|
gptkb:Ireland
|
|
gptkbp:relocated_headquarters_year
|
2013
|
|
gptkbp:revenue
|
$4.45 billion (2022)
|
|
gptkbp:servesArea
|
worldwide
|
|
gptkbp:stockExchange
|
gptkb:S&P_400
|
|
gptkbp:tradedOn
|
NYSE: PRGO
|
|
gptkbp:type
|
gptkb:public_company
|
|
gptkbp:website
|
https://www.perrigo.com/
|
|
gptkbp:bfsParent
|
gptkb:PRGO
|
|
gptkbp:bfsLayer
|
7
|